Skin cancer is the most common cancer in the U.S. More than 6 million adults are treated for it each year, says Dr. Michael Colgan, a Mayo Clinic Health System dermatologist in Eau Claire, Wisconsin.
Of Interest
Q&A: Changes in moles during pregnancy should not be ignored
Research suggests the impact of pregnancy on melanoma risk remains unclear.
Looking Ahead With TIL Therapy in Melanoma and Beyond
Last year’s FDA approval of lifileucel (Amtagvi) for metastatic melanoma marks a pivotal moment for TIL (tumor-infiltrating lymphocytes) therapy, establishing it as the first cellular therapy for a solid tumor. This breakthrough signals a future where TIL therapy could extend beyond melanoma, offering hope for patients with other hard-to-treat cancers. Here, Anuradha Krishnamurthy, MBBS, medical oncologist at Roswell Park Comprehensive Cancer Center, discusses this exciting field.
Common virus may improve skin cancer treatment outcomes
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.